Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GPIX | 49.67 | 0.20 | +0.40% |
| Goldman Sachs S&P 500 Premium Inc ETF | |||
| JAJL | 28.13 | 0.04 | +0.14% |
| Innovator Eq Dfnd Prot ETF - 6Mo Jan/Jul | |||
| ARKZ | 25.71 | N/A | N/A |
| ARK 21Shares Active Ethereum FutsStgyETF | |||
| SWAN | 30.32 | -0.01 | -0.03% |
| Amplify BlackSwan Gr & Trsry Cor ETF | |||
| WOMN | 39.08 | -0.28 | -0.72% |
| Impact Shares YWCA Women's Empwrmt ETF | |||
A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with NERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then NERV could also see price increases.
| Ticker / NAME | Correlation To ASPHF | 1D Price Change % | ||
|---|---|---|---|---|
| ASPHF | 100% | N/A | ||
| NERV - ASPHF | 44% Loosely correlated | -2.22% | ||
| GPCR - ASPHF | 31% Poorly correlated | N/A | ||
| NURPF - ASPHF | 30% Poorly correlated | N/A | ||
| PYPD - ASPHF | 24% Poorly correlated | -0.28% | ||
| GOSS - ASPHF | 24% Poorly correlated | -3.85% | ||
More | ||||